Siemens Healthineers

Siemens Healthineers is a leading medical technology company, spun off from Siemens in 2016 and publicly listed since 2018. They focus on diagnostic imaging, laboratory diagnostics, and advanced cancer therapy. While not a traditional venture capital fund, they act as a strategic investor through significant acquisitions and collaborative partnerships to expand their portfolio and market reach. Their investments aim to integrate innovative solutions that enhance their existing offerings and address global healthcare challenges, prioritizing patient-centered innovation and high-quality care. They invest heavily in research and development to bring breakthrough innovations to market.